ERİN, N. Et Al. 2021. Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC delta and PKC epsilon activators. CYTOKINE , vol.142 .

ERİN, N., Tavsan, E., Akdeniz, O., Isca, V. M. S., & Rijo, P., (2021). Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC delta and PKC epsilon activators. CYTOKINE , vol.142.

ERİN, NURAY Et Al. "Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC delta and PKC epsilon activators," CYTOKINE , vol.142, 2021

ERİN, NURAY Et Al. "Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC delta and PKC epsilon activators." CYTOKINE , vol.142, 2021

ERİN, N. Et Al. (2021) . "Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC delta and PKC epsilon activators." CYTOKINE , vol.142.

@article{article, author={NURAY ERİN Et Al. }, title={Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC delta and PKC epsilon activators}, journal={CYTOKINE}, year=2021}